Open research: how will the pharma/publisher relationship evolve in a new world?

Medical publishing is in the midst of a drive towards increased transparency, discoverability and open research, giving publishers more opportunities to educate for optimal health outcomes. 

In January 2020, Wiley convened a roundtable with 12 delegates from top global pharma companies, Wiley and open pharma. The aim: to build a better picture of the publisher/ pharma relationship, and discuss how it can evolve to maximize the potential of the digital age.